BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9656245)

  • 1. [Functional significance of p53 gene mutation in astrocytic neoplasms].
    Tada M
    No To Shinkei; 1998 Jun; 50(6):497-509. PubMed ID: 9656245
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways in the formation of gliomas.
    von Deimling A; Louis DN; Wiestler OD
    Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospect for research on deregulation of cell proliferation and apoptosis in human gliomas].
    Yu SZ; Sun ZM
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):547-9. PubMed ID: 16468301
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.
    Cai J; Chen J; Zhang W; Yang P; Zhang C; Li M; Yao K; Wang H; Li Q; Jiang C; Jiang T
    Oncotarget; 2015 Jul; 6(20):18105-15. PubMed ID: 25971279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay.
    Tada M; Iggo RD; Ishii N; Shinohe Y; Sakuma S; Estreicher A; Sawamura Y; Abe H
    Int J Cancer; 1996 Jul; 67(3):447-50. PubMed ID: 8707423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First p53 relative may be a new tumor suppressor.
    Dickman S
    Science; 1997 Sep; 277(5332):1605-6. PubMed ID: 9312855
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53: emergency brake and target for cancer therapy.
    Wiman KG
    Exp Cell Res; 1997 Nov; 237(1):14-8. PubMed ID: 9417861
    [No Abstract]   [Full Text] [Related]  

  • 14. Apoptosis and p53 expression in human gliomas.
    Sipos L; Szegedi Z; Fedorcsák I; Afra D; Szende B
    Pathol Oncol Res; 1998; 4(4):267-70. PubMed ID: 9887356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
    Bian XW; Shi JQ; Liu FX
    Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered structure and expression of the p53 gene in human neuroepithelial tumors.
    Tabuchi K; Fukuyama K; Mineta T; Oh-Uchida M; Hori K
    Neurol Med Chir (Tokyo); 1992 Sep; 32(10):725-32. PubMed ID: 1280773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology and molecular genetics of astrocytic neoplasms.
    Wong AJ; Zoltick PW; Moscatello DK
    Semin Oncol; 1994 Apr; 21(2):139-48. PubMed ID: 8153660
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrent sequence variation of TP53 and TP73 genes in anaplastic astrocytoma.
    Anselmo NP; Rey JA; Almeida LO; Custódio AC; Almeida JR; Clara CA; Santos MJ; Casartelli C
    Genet Mol Res; 2009 Oct; 8(4):1257-63. PubMed ID: 19876867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.